By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly regulated as the UK’s […]
Researchers at LVR University Hospital Essen in Germany have announced the results of a new study on the efficacy of medical cannabis in treating chronic depression. According to the findings, […]
Medical cannabis company MGC Pharma is pressing ahead with clinical trials despite ‘hurdles’ created by the pandemic. The London Stock Exchange-listed firm has reported updates on three separate trials planned […]
A new discovery by researchers shows that medical cannabis may reduce blood pressure in older adults. The study, published in the European Journal of Internal Medicine, is the first of […]
According to the World Health Organisation, depression affects more than 264 million people worldwide. There are numerous different approaches to treating mild, moderate and chronic depression. The first antidepressants were […]
Cannabis use is on the rise among US adults with depression, researchers have found. US adults with depression are twice as likely to use cannabis as those without, according to […]